176 related articles for article (PubMed ID: 11285198)
1. Intestinal toxicity and carcinogenic potential of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in DNA repair deficient XPA-/- mice.
Klein JC; Beems RB; Zwart PE; Hamzink M; Zomer G; van Steeg H; van Kreijl CF
Carcinogenesis; 2001 Apr; 22(4):619-26. PubMed ID: 11285198
[TBL] [Abstract][Full Text] [Related]
2. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J
Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818
[TBL] [Abstract][Full Text] [Related]
3. Delay of DNA-adduct repair and severe toxicity in xeroderma pigmentosum group A gene (XPA) deficient mice treated with 2-amino-1-methyl-6-phenyl-imidazo [4,5-b] pyridine (PhIP).
Imaida K; Ogawa K; Takahashi S; Ito T; Yamaguchi T; Totsuka Y; Wakabayashi K; Tanaka K; Ito N; Shirai T
Cancer Lett; 2000 Mar; 150(1):63-9. PubMed ID: 10755388
[TBL] [Abstract][Full Text] [Related]
4. Age at exposure and Apc status influence the levels of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in mouse intestine and liver.
Steffensen IL; Schut HA; Alexander J
Mutat Res; 2005 Nov; 587(1-2):73-89. PubMed ID: 16202642
[TBL] [Abstract][Full Text] [Related]
5. Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: perinatal susceptibility, regional variation, and correlation with DNA adducts.
Steffensen IL; Schut HA; Paulsen JE; Andreassen A; Alexander J
Cancer Res; 2001 Dec; 61(24):8689-96. PubMed ID: 11751386
[TBL] [Abstract][Full Text] [Related]
6. Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice.
Paulsen JE; Steffensen IL; Andreassen A; Vikse R; Alexander J
Carcinogenesis; 1999 Jul; 20(7):1277-82. PubMed ID: 10383901
[TBL] [Abstract][Full Text] [Related]
7. Mutagenesis and DNA adduct formation in the mouse mammary gland exposed to 2-hydroxyamino-1-methyl-6-phenylimidazo-[4,5-b]pyridine in whole organ culture.
Snyderwine EG; Yoon HS; Knight-Jones LP; Tran M; Schut HA; Yu M
Mutagenesis; 2003 Jan; 18(1):7-12. PubMed ID: 12473729
[TBL] [Abstract][Full Text] [Related]
8. Mlh1-dependent suppression of specific mutations induced in vivo by the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP).
Smith-Roe SL; Hegan DC; Glazer PM; Buermeyer AB
Mutat Res; 2006 Feb; 594(1-2):101-12. PubMed ID: 16256150
[TBL] [Abstract][Full Text] [Related]
9. Induction of intestinal tumors and lymphomas in C57BL/6N mice by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Ochiai M; Imai H; Sugimura T; Nagao M; Nakagama H
Jpn J Cancer Res; 2002 May; 93(5):478-83. PubMed ID: 12036442
[TBL] [Abstract][Full Text] [Related]
10. Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc(+) allele.
Andreassen A ; Vikse R; Steffensen IL; Paulsen JE; Alexander J
Mutagenesis; 2001 Jul; 16(4):309-15. PubMed ID: 11420398
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) into fur and correlation with intestinal tumourigenesis in Min/+ mice.
Steffensen IL; Janak K; Hegstad S; Andreassen A; Paulsen JE; Reistad R; Alexander J
Pharmacol Toxicol; 2003 Mar; 92(3):131-6. PubMed ID: 12753428
[TBL] [Abstract][Full Text] [Related]
12. Short-term carcinogenicity testing of a potent murine intestinal mutagen, 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP), in Apc1638N transgenic mice.
Sørensen IK; Kristiansen E; Mortensen A; van Kranen H; van Kreijl C; Fodde R; Thorgeirsson SS
Carcinogenesis; 1997 Apr; 18(4):777-81. PubMed ID: 9111214
[TBL] [Abstract][Full Text] [Related]
13. Induction of intestinal adenocarcinomas by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Nagase analbuminemic rats.
Ochiai M; Ogawa K; Wakabayashi K; Sugimura T; Nagase S; Esumi H; Nagao M
Jpn J Cancer Res; 1991 Apr; 82(4):363-6. PubMed ID: 1904414
[TBL] [Abstract][Full Text] [Related]
14. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats: dose-response studies.
Shirai T; Tamano S; Sano M; Masui T; Hasegawa R; Ito N
Princess Takamatsu Symp; 1995; 23():232-9. PubMed ID: 8844814
[TBL] [Abstract][Full Text] [Related]
15. Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2.
Kimura S; Kawabe M; Yu A; Morishima H; Fernandez-Salguero P; Hammons GJ; Ward JM; Kadlubar FF; Gonzalez FJ
Carcinogenesis; 2003 Mar; 24(3):583-7. PubMed ID: 12663521
[TBL] [Abstract][Full Text] [Related]
16. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is a potent mutagen in the mouse small intestine.
Brooks RA; Gooderham NJ; Zhao K; Edwards RJ; Howard LA; Boobis AR; Winton DJ
Cancer Res; 1994 Apr; 54(7):1665-71. PubMed ID: 8137279
[TBL] [Abstract][Full Text] [Related]
17. Use of DNA repair-deficient XPA transgenic mice in short-term carcinogenicity testing.
van Steeg H; Klein H; Beems RB; van Kreijl CF
Toxicol Pathol; 1998; 26(6):742-9. PubMed ID: 9864090
[TBL] [Abstract][Full Text] [Related]
18. Curcumin modifies Apc(min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apc(min) mice.
Collett GP; Robson CN; Mathers JC; Campbell FC
Carcinogenesis; 2001 May; 22(5):821-5. PubMed ID: 11323404
[TBL] [Abstract][Full Text] [Related]
19. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of PHIP intestinal mutations in MutaMouse.
Lynch AM; Gooderham NJ; Davies DS; Boobis AR
Mutagenesis; 1998 Nov; 13(6):601-5. PubMed ID: 9862191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]